Table 5 The effect of VAS/OPV on anthropometric parameters at baseline, 4 weeks, and 6 months after enrolment
Baseline | 4 weeks | 6 months | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VAS | OPV | Difference#/GMR¤ | RR | VAS | OPV | Difference#/GMR¤ | RR | VAS | OPV | Difference | RR | |
N = 77 | N = 82 | (95% CI) | (95% CI) | N = 63 | N = 66 | (95% CI) | (95% CI) | N = 67 | N = 73 | (95% CI) | (95% CI) | |
Age, days | 2 | 2 | 32 | 34 | 183 | 183 | ||||||
Length, | 44.9 | 45.2 | 0.99¤ | 48.3 | 49.5 | 0.45¤ | 63.0 | 63.6 | -0.32 | |||
cm* | (0.98-1.01) | (0.17-1.16) | (-1.31;0.67) | |||||||||
LAZ* | -3.01 | -2.84 | -0.17# | -3.38 | -2.89 | -0.28# | -2.16 | -1.93 | -0.13 | |||
(-0.54;0.20) | (-0.77;0.22) | (-0.59;0.34) | ||||||||||
Stunted* | 85% | 72% | 1.19 | 86% | 74% | 1.12 | 55% | 37% | 1.49 | |||
(1.00-1.40) | (0.94-1.33) | (0.98-2.23) | ||||||||||
Weight, | 2.05 | 2.13 | 0.96¤ | 2.84 | 3.10 | -0.26 # | 6.51 | 6.57 | -0.06 | |||
kg | (0.92-1.01) | (-0.46;-0.07) | (-0.43;0.31) | |||||||||
WAZ | -2.95 | -2.73 | -0.20# | -3.31 | -3.00 | -0.46 # | -3.20 | -3.06 | -0.11 | |||
(-0.47;0.08) | (-0.88;-0.04) | (-0.61;0.39) | ||||||||||
Under- | 97% | 99% | 0.99 | 87% | 73% | 1.20 | 48% | 29% | 1.68 | |||
weight | (0.94-1.03) | (1.01-1.43) | (1.04-2.73) | |||||||||
HC, cm | 31.0 | 31.3 | -0.27# | 35.3 | 35.6 | -0.22# | 42.6 | 42.8 | -0.16 | |||
(-0.85;0.31) | (-0.76;0.32) | (-0.72;0.40) | ||||||||||
HCAZ | -3.11 | -2.89 | -0.22# | -1.86 | -1.47 | -0.09# | -0.55 | -0.43 | -0.13 | |||
(-0.71;0.26) | (-0.55;0.37) | (-0.58;0.33) | ||||||||||
MUAC, | 7.7 | 7.9 | 0.80¤ | 9.4 | 10.1 | -0.50 # | 13.9 | 14.1 | -0.21 | |||
cm | (0.63-1.02) | (-0.93;-0.07) | (-0.65;0.23) | |||||||||
ACAZ | - | - | - | - | - | -0.35 | -0.15 | -0.19 | ||||
(-0.62;0.23) | ||||||||||||